Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27,382
Closed -$3.73M 899
2025
Q4
$3.73M Buy
27,382
+1,081
+4% +$155K 0.16% 160
2025
Q3
$3.88M Buy
26,301
+2,237
+9% +$310K 0.18% 146
2025
Q2
$3.11M Buy
24,064
+1,141
+5% +$138K 0.16% 167
2025
Q1
$2.74M Buy
22,923
+989
+5% +$123K 0.15% 170
2024
Q4
$2.54M Buy
+21,934
New +$2.77M 0.14% 170

Other funds holding XYL

IFG Advisory's XYL Position: Q1 2026 in Review

IFG Advisory sold out of Xylem (XYL) in Q1 2026, closing a stake of 27,382 shares — an estimated $3.73M sold.

IFG Advisory first reported a position in XYL in Q4 2024 and held it in 5 quarters. The position peaked at $3.88M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • IFG Advisory reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • IFG Advisory sold 27,382 Xylem shares in Q1 2026, an estimated $3.73M.
  • IFG Advisory first reported a position in Xylem in Q4 2024 and held it in 5 quarters.
  • IFG Advisory's Xylem position peaked at $3.88M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.